LYNN LOCHNER: Open Payments
NPI 1801238282 · KANKAKEE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,456 in 69 payments from 16 companies in 2025. Trend: 2023 $18,501 · 2024 $5,110 · 2025 $8,456
Consulting: $3,284Speaker / faculty: $2,500Food & beverage: $1,701Travel & lodging: $971
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $4,792 |
| ABBVIE INC. | 15 | $2,626 |
| Vanda Pharmaceuticals Inc. | 8 | $278 |
| Otsuka America Pharmaceutical, Inc. | 9 | $180 |
| Madrigal Pharmaceuticals | 1 | $142 |
| Supernus Pharmaceuticals, Inc. | 5 | $128 |
| Neurocrine BioSciences, Inc. | 4 | $92 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Alkermes, Inc. | 2 | $40 |
| Braeburn Inc. | 1 | $28 |
Products named: VRAYLAR, COBENFY, FANAPT, REZDIFFRA, Qelbree, REXULTI, ABILIFY ASIMTUFII, INGREZZA.
Industry payments across IL — which companies pay providers there.
